Remember Martin Shkreli?
The parasite who (ironically) bought the anti-parasite, and then raised the price by over 5,000%.
After the media sh%$ storm, he promised to lower the price.
Turing Pharmaceuticals AG will not reverse its decision to raise the price of a decades-old drug, Daraprim, by more than 5,000 percent, backing out of previous statements that it would cut the cost by the end of the year.
In an announcement on Tuesday, the company said that the list price of Daraprim, which jumped from $13.50 a pill to $750 a pill earlier this year, will not change. Instead, the company will offer hospitals up to 50 percent discounts and will make other adjustments to help patients afford Daraprim, a drug used to treat a parasitic infection and often given to HIV patients.
Out of the goodness of their hearts though, they will be selling a smaller bottle to make it a bit easier for hospitals to stock the drug.
We need villagers, torches, and pitchforks.